EPIC STEMI: Effects of routine early treatment with PCSK-9 inhibitor in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomized, double-blind, sham-controlled trial
EuroIntervention Journal
SR Mehta, G Pare, EM Lonn, SS Jolly, MK Natarajan, N Pinilla-Echeverri, JD Schwalm, T Sheth, M Sibbald, M Tang, N Valettas, JL Velianou, SF Lee, T Ferdous, S Nauman, H Nguyen, T McCready, MJ McQueen
September 2022